Saturday 17 October 2026
Export PAIYY’s income statement to Excel — free account
Aesthetic Medical International Hldngs Group Ltd Sponsored ADR
PAIYY Healthcare Medical Care Facilities
In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.
0.01
0.00
0.00%
Follow PAIYY
| Older periods | Mar '23 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.50 | 0.54 | 0.17 | 0.04 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
7.53 | 11.07 | 14.01 | 25.91 | |
Price to Tangible BV |
47.36 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.56 | 0.62 | 0.25 | 0.09 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(23.65) | (24.54) | (12.84) | (6.23) | |
EV/FCF |
(1.97) | (2.04) | (1.07) | (0.52) | |
Quick Ratio |
0.33 | 0.29 | 0.20 | 0.21 | |
Current Ratio |
0.38 | 0.35 | 0.24 | 0.24 | |
Net Debt/EBITDA |
21.85 | (4.39) | (3.46) | (12.23) | |
Debt/Assets |
24.43% | 23.49% | 21.51% | 16.32% | |
Debt/Equity |
3.62 | 4.44 | 10.95 | 42.40 | |
Asset Turnover |
1.04 | 1.06 | 1.52 | 2.21 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.35 | (1.22) | (2.89) | (1.09) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
45.12% | 50.04% | 48.76% | 41.52% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.07 | 0.07 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.26) | (1.17) | (2.88) | (8.01) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(31.35%) | (37.27%) | (51.54%) | (84.43%) | |
Free Cash Flow Yield |
(57.16%) | (56.20%) | (138.07%) | (404.36%) | |
Revenue per Share |
0.56 | 0.95 | 1.04 | 1.01 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.44 | 0.27 | 0.13 | 0.08 | |
Shareholders Equity per Share |
0.16 | 0.09 | 0.03 | 0.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.16 | 0.09 | 0.03 | 0.01 | |
Free Cash Flow |
— | — | — | — | |
Working Capital |
(44.55) | (41.02) | (43.41) | (41.87) | |
Net Current Asset Value |
(60.44) | (56.88) | (57.03) | (54.17) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.26 | 6.34 | 5.75 | 6.44 | |
Average Payables |
6.00 | 5.83 | 6.37 | 6.11 | |
Average Inventory |
3.97 | 3.79 | 3.34 | 3.09 | |
Average Assets |
92.21 | 84.04 | 76.21 | 74.51 | |
Average Common Equity |
(11.21) | (11.29) | (8.05) | (9.22) |
Columns are period end dates